Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse MKT  >  Lannett Company, Inc.    LCI

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops, manufactures and distributes generic prescription pharmaceutical products

Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products.

Its pharmaceutical products are distributed to drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations.

It also provides laboratory services which involves analytical, development, stability, and product identification; product formulation; granulation blending; encapsulation; compression; coating; and packaging. The company was founded in 1942 and is headquartered in Philadelphia, PA.
Managers
NameAgeSinceTitle
Arthur P. Bedrosian702000Chief Executive Officer & Director
Jeffrey Farber562003Chairman
Martin P. Galvan, CPA642011CFO, Treasurer & Vice President-Finance
Robert Ehlinger592006Chief Information Officer & VP-logistics
David A. Drabik482010Lead Independent Director
Paul Taveira562012Independent Director
James M. Maher632013Independent Director
Albert R. Paonessa III562015Independent Director
Kevin R. Smith562002Senior Vice President-Sales & Marketing
Mahendra Dedhiya PhD, MBA672015Vice President-Scientific Affairs
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 37,438,340 27,280,321 72.9% 545,963 1.5% 72.9%
Shareholders
NameEquities%
Telemus Capital LLC 5,854,310 15.9%
Jeffrey Farber 4,691,495 12.8%
BlackRock Fund Advisors 2,736,183 7.45%
The Vanguard Group, Inc. 2,059,084 5.60%
Invesco PowerShares Capital Management LLC 2,019,632 5.50%
David Farber 1,876,313 5.11%
Coatue Management LLC 1,805,431 4.91%
SSgA Funds Management, Inc. 1,144,621 3.11%
Thompson, Siegel & Walmsley LLC 901,490 2.45%
Deerfield Management Company LP 895,591 2.44%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
LANNETT COMPANY, INC.1 228
JOHNSON & JOHNSON16.18%326 855
ROCHE HOLDING LTD.-12.84%214 220
PFIZER INC.7.81%211 570
NOVARTIS AG-10.02%209 772
ASTRAZENECA PLC7.33%174 031
MERCK & CO., INC.18.88%173 406
GLAXOSMITHKLINE PLC19.37%104 943
SANOFI-11.77%100 142
BRISTOL-MYERS SQUIBB C..-16.57%95 640
NOVO NORDISK A/S-22.28%95 229
ALLERGAN PLC-24.95%93 837
BAYER AG-16.02%89 651
ELI LILLY AND CO-7.73%85 846
ABBOTT LABORATORIES-6.44%62 960
SHIRE PLC3.24%57 132
TEVA PHARMACEUTICAL IN..-24.95%51 313
TAKEDA PHARMACEUTICAL ..-24.00%34 883
ASTELLAS PHARMA INC-8.00%33 414
MYLAN NV-21.66%22 867
EISAI CO., LTD-23.80%17 400
Sector Pharmaceuticals - NEC
Lannett Company, Inc. : Connections
Cranbrook & Co. Llc
Generic Pharmaceutical Co.
Auburn Pharmaceuticals, Inc.
Grason-Stadler, Inc.
National Response Corp.
The American Institute of Certified Public Accountants
Healthcare Distribution Management Association
Company contact information
Lannett Co., Inc.
13200 Townsend Road
Philadelphia, PA 19154

Phone : +1.215.333.9000
Fax : +1.215.333.9004
Web : www.lannett.com
© 2016 People , Fundamentals and Ownership